机译:添加无载体与添加有载体的123 I-蛋氨酸苄基胍(MIBG)评估心脏交感神经活动的临床表现和放射线剂量
Department of Nuclear Medicine Academic Medical Center University of Amsterdam F2-238 P.O. Box 22700 1100 DE Amsterdam The Netherlands;
Department of Nuclear Medicine Academic Medical Center University of Amsterdam F2-238 P.O. Box 22700 1100 DE Amsterdam The Netherlands;
Department of Nuclear Medicine Academic Medical Center University of Amsterdam F2-238 P.O. Box 22700 1100 DE Amsterdam The Netherlands;
Department of Nuclear Medicine Academic Medical Center University of Amsterdam F2-238 P.O. Box 22700 1100 DE Amsterdam The Netherlands;
Mallinckrodt Medical Tyco Healthcare BV Petten The Netherlands;
Vanderbilt University Nashville TN USA;
Department of Cardiology Onze Lieve Vrouwe Gasthuis Amsterdam The Netherlands;
Department of Nuclear Medicine Academic Medical Center University of Amsterdam F2-238 P.O. Box 22700 1100 DE Amsterdam The Netherlands;
Cardiology; Heart failure; Sympathetic innervation; 123I-MIBG; Dosimetry;
机译:未加载体与加载体(123)I-甲氧苄基胍(MIBG)的临床性能和放射线剂量法评估心脏交感神经活动。
机译:评估心脏交感神经活动时,未添加载体的载体与添加了载体的123I-甲酰氨基苄基胍相比。
机译:使用I-123 MIBG成像评估扩张型心肌病患者中枢性睡眠呼吸暂停综合征的中枢化学敏感性和心脏交感神经活动
机译:用于心脏交感神经活动评估的便携式NeuECG监测系统
机译:心脏交感神经末梢的变化与铁缺乏症的发展有关。
机译:添加无载体与添加有载体的123I-甲氧苄基胍(MIBG)的临床性能和放射线剂量法评估心脏交感神经活动
机译:添加无载体与添加有载体的123I-蛋氨酸苄基胍(MIBG)的临床性能和放射线剂量法评估心脏交感神经活动